¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"galactose diabetes"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • insulin-resistant diabetes
    Àν¶¸°ÀúÇ×´ç´¢º´
  • juvenile diabetes
    ¼Ò¾Æ´ç´¢º´
  • latent diabetes
    ÀáÀç´ç´¢º´
  • lipogenous diabetes
    Áö¹æÇü¼º´ç´¢º´
  • lipuric diabetes
    Áö¹æ´¢´ç´¢º´
  • masked diabetes
    Àẹ´ç´¢º´
  • maturity-onset diabetes
    ¼º¼÷±â¹ßº´´ç´¢º´, ¼ºÀιߺ´´ç´¢º´
  • nephrogenic diabetes insipidus
    ÄáÆÏ±â¿ø¿äºØÁõ, ½ÅÀå±â¿ø¿äºØÁõ
  • neurogenic diabetes insipidus
    ½Å°æ¼º¿äºØÁõ
  • non-insulin-dependent diabetes
    ºñÀν¶¸°ÀÇÁ¸´ç´¢º´
  • overt diabetes
    Çö¼º´ç´¢º´
  • pancreatic diabetes
    ÀÌÀÚ´ç´¢º´, ÃéÀå´ç´¢º´
  • starvation diabetes
    ±â¾Æ´ç´¢º´
  • stress diabetes
    ½ºÆ®·¹½º´ç´¢º´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • iatrogenic diabetes
    ÀÇ¿ø´ç´¢º´
  • insulin-dependent diabetes
    Àν¶¸°ÀÇÁ¸´ç´¢º´
  • insulin-resistant diabetes
    Àν¶¸°ÀúÇ×´ç´¢º´
  • juvenile diabetes
    ¼Ò¾Æ´ç´¢º´
  • latent diabetes
    ÀáÀç´ç´¢º´
  • lipogenous diabetes
    Áö¹æ»ý¼º´ç´¢º´
  • lipuric diabetes
    Áö¹æ´¢´ç´¢º´
  • masked diabetes
    ÀáÀç´ç´¢º´
  • maturity-onset diabetes
    ¼ºÀδ索º´
  • non-insulin-dependent diabetes
    ºñÀν¶¸°ÀÇÁ¸´ç´¢º´
  • overt diabetes
    Çö¼º´ç´¢º´
  • pancreatic diabetes
    ÃéÀå´ç´¢º´, ÀÌÀÚ´ç´¢º´
  • starvation diabetes
    ±â¾Æ´ç´¢º´
  • stress diabetes
    ½ºÆ®·¹½º´ç´¢º´
  • neurogenic diabetes insipidus
    ½Å°æÅ¿´¢ºØÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • iatrogenic diabetes
    ÀÇ(¿ø)¼º ´ç´¢º´(ì¢ê«àõÓØèñÜ»), ÀÇÀμº ´ç´¢º´.
  • phosphate diabetes
    Àλ꿰´ç´¢
  • pituitary diabetes
    Çϼöü¼º ´ç´¢º´(ù»á÷ô÷àõ ÓØèñÜ»)
  • renal diabetes
    ½Å¼º ´ç´¢º´(ãìàõÓØèñÜ»).
  • renal diabetes
    ½Å¼º ´ç´¢º´(ãìàõÓØèñÜ»)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diabetes albuminicus<³ª>
    ´Ü¹é¼º ´ç´¢(º´)(Ó±ÛÜàõÓØèñÜ»).
  • diabetes albuminurinicus<³ª>
    ´Ü¹é´¢¼º ´ç´¢(º´)(¡­ÓØèñÜ»).
  • diabetes alternans<³ª>
    ±³´ë¼º ´ç´¢(º´)(ÎßÓÛàõÓØèñÜ»).
  • diabetes decipiens
    °¡¼º´ç´¢º´(Ê£àõ ÓØèñÜ»).
  • diabetes innocens<³ª>
    ºñÃ鼺 ´ç´¢º´.
  • diabetes insipidus
    ¿äºØÁõ(èñÝÚñø)
  • diabetes insipidus<³ª>
    ¿äºØÁõ(èñÝÚñø).
  • diabetes inspidus
    ¿äºØÁõ(èñÝÚñø)
  • diabetes inspidus
    ¿äºØÁõ(èñÝÚñø)
  • diabetes intermittens<³ª>
    °£Ç漺 ´ç´¢(º´).
  • diabetes mellitus
    (Áø¼º)´ç´¢º´(òØàõÓØÒãÜ»)
  • diabetes mellitus
    ´ç´¢º´(ÓØÒãÜ»)
  • diabetes mellitus
    ´ç´¢º´(ÓØÒãÜ»)
  • diabetes mellitus,adult-onset
    ¼ºÀιߺ´Çü(à÷ìÑÛ¡Ü»úþ)
  • diabetes mellitus,insulin deficiency
    Àν¶¸° °áÇÌÁõ(¡­ÌÀù¹ñø)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
gal galactose; gallon
GALBP galactose-binding protein
GALE galactose epimerase
Gal-1-P galactose-1-phosphate
GALT galactose-1-p-uridyltransferase; gut-associated lymphoid tissue
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
UDP-Gal UDP-galactose
GALE UDP-galactose 4' epimerase
CGalt UDP-galactose-ceramide galactosyl transferase
CGT UDP-galactose:ceramide galactosyl transferase
GOS galactose oxidase Schiff
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
galactose tolerance test A liver function test, based on the ability of the liver to convert galactose to glycogen, measured by the rate of excretion of galactose following ingestion or intravenous injection of a known amount; normally, less than 3 g appear in the urine within 5 hours after the ingestion of 40 g.
(05 Mar 2000)
UDPgalactosamine-galactose acetylgalactosaminyltransferase <enzyme> Transfers sugars from udp-n-acetylgalactosamine to terminal galactose of h substance, producing a antigen; consider also fucosyl galactose alpha-n-acetylgalactosaminyltransferase which is called a-transferase
Registry number: EC 2.4.1.-
Synonym: blood group a-enzyme, blood group glycosyltransferase a, alpha-3-d-n-acetylgalactosaminyltransferase, alpha-3-n-acetyl-d-galactosaminyltransferase
(26 Jun 1999)
UDP-galactose 4-O-beta-D-galactosyl-D-xylose galactosyltransferase <enzyme> Involved in chondroitin sulfate synthesis
Registry number: EC 2.4.1.-
(26 Jun 1999)
UDP-galactose hydrolase <enzyme> Hydrolyzes udp-galactose to galactose
Registry number: EC 3.1.4.-
(26 Jun 1999)
UDP-galactose-lactosylceramide alpha 1-4-galactosyltransferase <enzyme> Catalyses transfer of galactose from udp-galactose to lactosylceramide; exclusively an alpha1-4-galactosyltransferase
Registry number: EC 2.4.1.-
Synonym: udpgal-galactosyl-beta-1-4-glucosylceramide alpha1-4-galactosyltransferase, globotriaosylceramide synthase, udp-glcg-transferase, udp galactose lactosylceramide alpha-galactosyltransferase, udp-gal lcgtase, udp-gal-galactose alpha(1,4)-galactosyltransferase, alpha1,4galt
(26 Jun 1999)
UDP-galactose-lactosylceramide beta 1-3-galactosyltransferase <enzyme> Catalyses transfer of galactose from udp-galactose to lactose or lactosylceramide
Registry number: EC 2.4.1.-
Synonym: udp-galactose-lactose beta 1-3 galactosyltransferase, udp-galactose-lactose (lactosylceramide) beta-3-galactosyltransferase, udpgal-lac-3-transferase
(26 Jun 1999)
UDP-galactose xylose galactosyltransferase <enzyme> Involved in chondroitin sulfate synthesis
Registry number: EC 2.4.1.-
(26 Jun 1999)
UDP-GalNAc-beta-galactose beta 1,4-N-acetylgalactosaminyltransferase <enzyme> Consider also EC 2.4.1.92
Registry number: EC 2.4.1.-
Synonym: beta-1,4-n-acetylgalactosaminyltransferase, 4-galnactransferase, udp-n-acetylgalactosamine-beta-galactose beta 1,4-n-acetylgalactosaminyltransferase, (1-4)-n-acetyl-beta-d-galactosaminyltransferase, galnact-1
(26 Jun 1999)
UDP-N-acetylglucosamine-galactose(1-6)-N-acetylglucosaminyltransferase <enzyme> Forms oligosaccharide core class 4(glcnac beta 1-3(glcnac beta 1-6)galnac) in mucins and various glycoproteins
Registry number: EC 2.4.1.148
Synonym: udp-nagagf
(26 Jun 1999)
uridine diphosphate galactose <chemical> A nucleoside diphosphate sugar which can be epimerised into udpglucose for entry into the mainstream of carbohydrate metabolism. Serves as a source of galactose in the synthesis of lipopolysaccharides, cerebrosides, and lactose.
Chemical name: Uridine 5'-(trihydrogen diphosphate), P'-alpha-D-galactopyranosyl ester
(12 Dec 1998)
2-amino-2-deoxy-D-galactose <chemical> Chemical name: D-Galactose, 2-amino-2-deoxy-
(12 Dec 1998)
fucosyl galactose alpha-n-acetylgalactosaminyltransferase <enzyme> An enzyme that catalyses the transfer of acetylgalactosamine from udp n-acetylgalactosamine to various 2-fucosylgalactosides as acceptors.
Chemical name: UDP-N-acetyl-D-galactosamine:alpha-L-fucosyl-(1,2)-D-galactose 3-N-acetyl-D-galactosaminyltransferase
Registry number: EC 2.4.1.40
(12 Dec 1998)
adult-onset diabetes <disease> An often mild form of diabetes mellitus of gradual onset, usually in obese individuals over age 35; absolute plasma insulin levels are normal to high, but relatively low in relation to plasma glucose levels; ketoacidosis is rare, but hyperosmolar coma can occur; responds well to dietary regulation and/or oral hypoglycaemic agents, but diabetic complications and degenerative changes can develop.
(05 Mar 2000)
alimentary diabetes Glycosuria developing after the ingestion of a moderate amount of sugar or starch, which normally is disposed of without appearing in the urine, because rate of intestinal absorption exceeds capacity of the liver and the other tissues to remove the glucose, thus allowing blood glucose levels to become high enough for renal excretion to occur.
Synonym: alimentary diabetes, digestive glycosuria.
(05 Mar 2000)
alloxan diabetes Experimental diabetes mellitus produced in animals by the administration of alloxan, which damages the insulin-producing islet cells of the pancreas.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á